LAUREATE EDUCATION, INC.

LAUR

Held by 1 specialist biotech fund

Fund Holdings

AI Signal

**Signal Note: Driehaus Position in LAUR** This signal appears misaligned with Driehaus's biotech focus—LAUR is an education/online learning company, not a biopharmaceutical firm.

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 375,002Value: $12.6M

**Signal Note: Driehaus Position in LAUR** This signal appears misaligned with Driehaus's biotech focus—LAUR is an education/online learning company, not a biopharmaceutical firm. The $12.6M position (375k shares) likely reflects portfolio diversification or a tactical trade rather than core biotech thesis activity. Without clarity on Driehaus's rationale, this warrants monitoring as either a data error or a notable strategic pivot away from pure biotech concentration.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: